Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04471974 |
|---|---|
| Brief Title: | ZEN-3694, Enzalutamide, and Pembrolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer |
| First Submitted : | July 10, 2020 |
| First Submitted that Met QC Criteria : | July 10, 2020 |
| First Posted : | July 15, 2020 |
| Last Update Submitted that Met QC Criteria : | February 14, 2022 |
| Last Update Posted : | March 3, 2022 |